Santa Cruz, Calif. – SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing small RNAs, including micro-RNAs and small fragments of large RNAs. Further terms of the agreement were not disclosed.

The RealSeq®-AC platform is a novel technology that dramatically reduces sequencing bias compared to standard methods for preparing libraries for small RNA sequencing. RealSeq®-AC allows detection and discovery of many small RNAs that are often underestimated by up to 104-fold of their true abundance.

“We are excited to commercialize our RealSeq®-AC technology with Rubicon Genomics, given their impressive product portfolio and market position in the area of next generation sequencing sample preparation,” said Brian Johnston, Ph.D., President and CEO of SomaGenics.

Rubicon Genomics is a leading worldwide provider of pre-analytical library preparation kits t